China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review
16 Mar 2015
Financial Statement
Recently added to the BioPortfolio report store,
China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review is a new report from
GlobalData published on 2015-01-31.
This 25-page report
is available in PDF
from $300.
Summary
China Shineway Pharmaceutical Group Limited (China Shineway) is a pharmaceutical company. The company develops, manufactures and sells modern chinese medicine. Its products include shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft capsules, qingkailing soft capsules, coryza soft capsules, vitamin E soft capsules, banlangen granules, ganmao qingre granules, yening granules, cefalexin granules, xiesaitong dripping pills, liuwei dihuang wan, and aspirin tablets. The company's products are used in treatment of coronary heart disease, viral cardiac muscle inflammation, chronic pulmonary heart disease, cardiac cerebrovascular diseases, chronic tonsillitis, pharyngitis, stomatitis and parotitis, and agranulocytosis, among others. It markets its products under brands, SHINEWAY and WU FU. China Shineway is headquartered in Wanchai, Hong Kong.
This comprehensive SWOT profile of China Shineway Pharmaceutical Group Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of China Shineway Pharmaceutical Group Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is…
Table of Contents
Section 1 - About the Company
China Shineway Pharmaceutical Group Limited - Key Information
China Shineway Pharmaceutical Group Limited - Overview
China Shineway Pharmaceutical Group Limited - Key Employees
China Shineway Pharmaceutical Group Limited - Key Employee Biographies
China Shineway Pharmaceutical Group Limited - Key Operational Heads
China Shineway Pharmaceutical Group Limited - Major Products and Services
China Shineway Pharmaceutical Group Limited - History
China Shineway Pharmaceutical Group Limited - Company Statement
China Shineway Pharmaceutical Group Limited - Locations And Subsidiaries
China Shineway Pharmaceutical Group Limited - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
China Shineway Pharmaceutical Group Limited - Business Description
China Shineway Pharmaceutical Group Limited - Corporate Strategy
China Shineway Pharmaceutical Group Limited - SWOT Analysis
SWOT Analysis - Overview
China Shineway Pharmaceutical Group Limited - Strengths
China Shineway Pharmaceutical Group Limited - Weaknesses
China Shineway Pharmaceutical Group Limited - Opportunities
China Shineway Pharmaceutical Group Limited - Threats
China Shineway Pharmaceutical Group Limited - Key Competitors
Section 3 - Company Financial Performance Charts
China Shineway Pharmaceutical Group Limited - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Appendix
Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Note*: Some sections may be missing if data is unavailable for the company
For more information open China Shineway Pharmaceutical Group Limited (2877) - Financial and Strategic SWOT Analysis Review.
SKU: GDPH138731FSA
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.